Krassimir Mitchev

Krassimir Mitchev is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as the VP of Clinical Development Portfolio and Chief Medical Officer at Calliditas Therapeutics since March 2019. Concurrently, Krassimir operates as the Owner and Director of Arden Regulatory Clinical & Medical Consulting Limited since July 2018. Previous roles include Clinical/Medical at Santhera Pharmaceuticals and VP, Head Therapeutic Area Haemophilia Medical at Sobi, where responsibilities encompassed therapeutic area development and medical leadership. Krassimir has also held significant positions at GlaxoSmithKline and UCB Pharma, focusing on medical affairs, strategy execution, and successful drug launches across various therapeutic areas such as Immunology and Hepatitis. With a strong emphasis on evidence generation, stakeholder engagement, and team leadership, Krassimir has consistently contributed to advancing healthcare solutions.